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Abstract
Background: Radiotherapy outcomes are usually predicted using the Linear Quadratic model.
However, this model does not integrate complex features of tumor growth, in particular cell cycle
regulation.
Methods: In this paper, we propose a multiscale model of cancer growth based on the genetic and
molecular features of the evolution of colorectal cancer. The model includes key genes, cellular
kinetics, tissue dynamics, macroscopic tumor evolution and radiosensitivity dependence on the cell
cycle phase. We investigate the role of gene-dependent cell cycle regulation in the response of
tumors to therapeutic irradiation protocols.
Results: Simulation results emphasize the importance of tumor tissue features and the need to
consider regulating factors such as hypoxia, as well as tumor geometry and tissue dynamics, in
predicting and improving radiotherapeutic efficacy.
Conclusion: This model provides insight into the coupling of complex biological processes, which
leads to a better understanding of oncogenesis. This will hopefully lead to improved irradiation
therapy.
Background
Mathematical models of cancer growth have been the sub-
ject of research activity for many years. The Gompertzian
model [1,2], logistic and power functions have been
extensively used to describe tumor growth dynamics (see
for example [3] and [4]). These simple formalisms have
been also used to investigate different therapeutic strate-
gies such as antiangiogenic or radiation treatments [5].
The so-called linear-quadratic (LQ) model [6] is still
extensively used, particularly in radiotherapy, to study
damage to cells by ionizing radiation. Indeed, extensions
of the LQ model such as the 'Tumor Control Probability'
model [7] are aimed at predicting the clinical efficacy of
radiotherapeutic protocols. Typically, these models
assume that tumor sensitivity and repopulation are con-
stant during radiotherapy. However, experimental evi-
dence suggests that cell cycle regulation is perhaps the
most important determinant of sensitivity to ionizing
radiation [8]. It has been suggested that anti-growth sig-
nals such as hypoxia or the contact effect, which are
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responsible for decreasing the growth fraction, may play a
crucial role in the response of tumors to irradiation [9].
Nowadays, computational power allows us to build math-
ematical models that can integrate different aspects of the
disease and can be used to investigate the role of complex
tumor growth features in the response to therapeutic pro-
tocols [10]. In the present study we propose a multiscale
model of tumor evolution to investigate growth regula-
tion in response to radiotherapy. In our model, key genes
in colorectal cancer have been integrated within a Boolean
genetic network. Outputs of this genetic model have been
linked to a discrete model of the cell cycle where cell radi-
osensitivity has been assumed to be cycle phase specific.
Finally, Darcy's law has been used to simulate macro-
scopic tumor growth.
The multiscale model takes into account two key regula-
tion signals influencing tumor growth. One is hypoxia,
which appears when cells lack oxygen. The other is over-
population, which is activated when cells do not have suf-
ficient space to proliferate. These signals have been
correlated to specific pathways of the genetic model and
integrated up to the macroscopic scale.
Methods
Oncogenesis is a set of sequential steps in which an inter-
play of genetic, biochemical and cellular mechanisms
(including gene pathways, intracellular signaling path-
ways, cell cycle regulation and cell-cell interactions) and
environmental factors cause normal cells in a tissue to
develop into a tumor. The development of strategies for
treating oncogenesis relies on the understanding of patho-
Multiscale nature of the model Figure 1
Multiscale nature of the model. Schematic view of the multiscale nature of the model, composed of four different levels. At 
the genetic level we integrate the main genes involved in the evolution of colorectal cancer within a Boolean network and this 
results in cell cycle regulation signals. The response to these signals occurs at the cellular level, determining whether each cell 
proliferates or dies. Given this information, the macroscopic model the new spatial distribution of the cells is computed at the 
tissue level. The number and spatial configuration of cells determine the activation of the antigrowth signals, which in turn is 
input to the genetic level. Irradiation induces DNA breaks, which, in the model, activate the p53 gene at the genetic level.Theoretical Biology and Medical Modelling 2006, 3:7 http://www.tbiomed.com/content/3/1/7
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genesis at the cellular and molecular levels. We have there-
fore developed a multiscale mathematical model of these
processes to study the efficacy of radiotherapy. Several
mathematical frameworks have been developed to model
avascular and vascular tumor growth (see [11-14]). Here
we propose a multiscale mathematical model for avascu-
lar tumor growth, which is schematically presented in Fig-
ure 1. This model provides a powerful tool for addressing
questions of how cells interact with each other and their
environment. We use the model to study tumor regression
during radiotherapy.
Gene level
Five genes are commonly mutated in colorectal cancer
patients, namely: APC (Adenomatosis Polyposis Coli), K-
RAS  (Kirsten Rat Sarcoma viral), TGF  (Transforming
Growth Factor), SMAD (Mothers Against Decapentaple-
gic) and p53 or TP53 (Tumor Protein 53). These genes
belong to four specific pathways, which funnel external or
internal signals that cause cell proliferation or cell death
(see [15] and [16,17] for more details).
The anti-growth, p53, pathway is activated in the case of
DNA damage [18,19]. This is particularly relevant during
irradiation [20]. p53 pathway activation can block the cell
cycle and induce apoptosis [21,22]. The K-RAS  gene
belongs to a mitogenic pathway that promotes cell prolif-
eration in the presence of growth factors [23]. Activation
of the anti-growth pathways TGFβ/SMAD and WNT/APC
inhibits cell proliferation. The SMAD gene is activated by
hypoxia signals [24,25], while APC is activated through β-
catenin by loss of cell-cell contact [26-30]. Moreover, it
Cell proliferation and death (genetic regulation) for colorectal cancer Figure 2
Cell proliferation and death (genetic regulation) for colorectal cancer. This figure shows the genetic model with reg-
ulation signals as inputs. p53 is activated when DNA is damaged and leads the cell to apoptosis. SMAD is activated through 
TGFβ receptors during hypoxia and inhibits cell proliferation. Overpopulation inhibits cell proliferation through activation of 
APC. RAS promotes cell proliferation through growth factor receptors when sufficient oxygen is available for the cell, that is, 
there is no hypoxia. This flow chart was developed from knowledge available from bibliographic resources [15,16] and from 
the Knowledge Encyclopedia of Genes and Genomes [53,54].Theoretical Biology and Medical Modelling 2006, 3:7 http://www.tbiomed.com/content/3/1/7
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has recently been hypothesized that overpopulation of
APC mutated cells can explain the shifts of normal prolif-
eration in early colon tumorigenesis [31].
We assume that activation of APC and SMAD is due to
overpopulation and hypoxia signals respectively. Both
pathways inhibit cell proliferation. In consequence, APC
mutated cells promote overpopulation and SMAD or RAS
mutated cells promote proliferation during hypoxia. Fig-
ure 2 shows the schematic genetic model.
We develop a Boolean model of these pathways in Figure
2. Each gene is represented by a node in the network and
the interactions are encoded as the edges. The state of each
node is 1 or 0, corresponding to the presence or absence
of the genetic species. The state of a node can change with
time according to a logical function of its state and the
states of other nodes with edges incident on it [32-34].
The rules governing the genetic pathways are presented in
Table 2.
Cell level
We consider a discrete mathematical model of the cell
cycle in which the cycle phase duration values were set
according to the literature [35]. In our model the prolifer-
ative cycle is composed of three distinct phases: S (DNA
synthesis), G1 (Gap 1) and G2M (Mitosis). We model the
'Restriction point' R [36] at the end of G1 where internal
and external signals, i.e. cell DNA damage, overpopula-
tion and hypoxia, are checked [37] (see Figure 3 for a sche-
matic representation of our cell cycle model).
For each spatial position (x, y), we assume that:
- If the local concentration of oxygen is below a constant
threshold Tho and if SMAD  is not mutated, hypoxia is
declared and causes cells to quiesce (G0) through SMAD
gene activation (see Figure 2);
- If the local number of cells is above a constant threshold
Tht and if APC is not mutated, overpopulation is declared
and leads cells to quiesce (G0) through the APC gene (see
Figure 2);
- Otherwise, if the conditions are appropriate, cells enter
G2M and divide, generating new cells at the same spatial
position.
Induction of apoptosis through p53 gene activation is dis-
cussed later.
Tissue level
We use a fluid dynamics model to describe tissue behav-
ior. This macroscopic-level continuous model is based on
Darcy's law, which is a good model of the flow of tumor
cells in the extracellular matrix [38-40]:
v = -k∇p   (1)
Table 2: Genetic model. Boolean (logical) functions used in the 
genetic model depicted Figure 1. For APC, SMAD and RAS, 
Boolean values are set to 0, 0 and 1 respectively when genes are 
mutated.
Boolean model
Node Boolean updating function
APCt
APCt+1 = 0 if mutated
βcatt βcatt+1 = ¬APCt
cmyct cmyct+1 = RASt ∧ βcatt ∧ ¬SMADt
p27t p27t+1 = SMADt ∨ ¬cmyct
p21t p21t+1 = p53t
Baxt Baxt+1 = p53t
SMADt
SMADt+1 = 0 if mutated
RASt
RASt+1 = 1 if mutated
p53t
p53t+1 = 0 if mutated
CycCDKt CycCDKt+1 = ¬p21t ∧ ¬p27t
Rbt Rbt+1 = ¬CycCDKt
APC
if Overpopulation signal
otherwise
t+ =



1 1
0
  
SMAD
if Hypoxia signal
otherwise
t+ =



1 1
0
  
RAS
if no Hypoxia signal
otherwise
t+ =



1 1
0
    
p
if DNA damage signal
otherwise
t 53
1
0
1 + =



    
Table 1: Apoptotic activity. Apoptotic activity induced by two 20 Gy radiotherapy protocols applied to APC-mutated tumor cells.
Apoptotic activity
Total dose (Gy) Scheduling Apoptotic fraction – mean – (%) Apoptotic fraction – max – (%)
Standard protocol 20 2 Gy daily 2.59 4
Heuristic 20 2 Gy Repeated 10 times before hypoxia 3.14 4.25Theoretical Biology and Medical Modelling 2006, 3:7 http://www.tbiomed.com/content/3/1/7
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where p is the pressure field. The media permeability k is
assumed to be constant.
We study the evolution of the cell densities in two dimen-
sions. We formulate the cell densities in the tissue mathe-
matically as advection equations, where nφ(x,  y,  t)
represents the density of cells with position (x, y) at time t
in a given cycle phase φ. Assuming that all cells move with
the same velocity given by Eq. (1) and applying the prin-
ciple of mass balance, the advection equations are:
where Pφ is the cell density proliferation term in phase φ at
time t, retrieved from the cell cycle model.
The global model is an age-structured model (see Section
2.7). Initial conditions for nφ are presented in Section 2.6.
Assuming   to be a constant and adding Eq. (2) for
all phases, the pressure field p satisfies:
The pressure is constant on the boundary of the computa-
tional domain.
In our model, the oxygen concentration C follows a diffu-
sion equation with Dirichlet conditions on the edge of the
computation domain Ω:
C = Cmax   on   Ωbv   (5)
∂
∂
ϕ
ϕ
ϕϕ
n
t
vn P G S G M G Apop +∇⋅ = ∀ ∈{} () () , , , , 120 2
nϕ ϕ ∑
−∇⋅ ∇ = () ∑ () . kp P ϕ
ϕ
3
∂
∂
αϕϕ
ϕ
C
t
DC n o n bv −∇⋅ ∇ =− () ∑ () ΩΩ 4
Diagram of the cell cycle model Figure 3
Diagram of the cell cycle model. In this discrete model, cells progress through a cell cycle comprising three phases: G1, S, 
and G2M. At the end of the G2M phase, cells divide and new cells begin their cycle in G1. At the last stage of phase G1, we mod-
elled the restriction point R, where DNA integrity and external conditions (overpopulation and hypoxia) are checked. If over-
population occurs, APC is activated; if hypoxia occurs, SMAD is activated. Both these conditions lead cells to G0 (quiescence). 
Cells remain in the quiescent phase in the absence of external changes, otherwise they may return to the proliferative cycle (at 
the first step of S phase). DNA damage can also activate the p53 pathway, which leads cells to the apoptotic phase. Cells at the 
end of the apoptotic phase die and disappear from the computational domain.Theoretical Biology and Medical Modelling 2006, 3:7 http://www.tbiomed.com/content/3/1/7
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C∂Ω = 0   (6)
D is the oxygen diffusion coefficient, which is constant
throughout the computation domain. In this equation,
Ωbv stands for the spatial location of blood vessels, αφ is
the coefficient of oxygen uptake by cells at cell cycle phase
φ and Cmax is the constant oxygen concentration in blood
vessels.
Therapy assumptions
Cell sensitivity depends on cell cycle phase [8]. We
assume that only proliferative cells are sensitive to the
treatment. In addition, we assume that DNA damage is
proportional to the irradiation dose. This is known as the
'single hit' theory, which is governed by the expression
ndsb = Rφd   (7)
where ndsb is the number of double strand breaks induced
by radiation dose d. As mentioned previously, the radio-
sensitivity Rφ has been assumed to depend on the cell cycle
phase (see Table 3). Based upon radiobiological experi-
ments found in the literature, we take the radiosensitivity
as constant (2 Gy-1) in G1 and G0. It decreases in S phase
to 0.2 Gy-1, and then increases to 2 Gy-1 during G2.
We set a constant treatment threshold Thr such that if ndsb
due to the irradiation dose is above Thr at any time, p53 is
activated and the cells are labeled as 'DNA damaged cells'.
DNA damaged cells are identified at the R point of the cell
cycle and are directed to apoptosis. They die and disap-
pear from the computational domain after TApoptosis, i.e. the
duration of the apoptotic phase.
The standard radiotherapy protocol used in the simula-
tions consists of a 2 Gy dose delivered each day, five days
a week, and can be repeated for several weeks. The radio-
therapeutic dose is assumed to be uniformly distributed
over the spatial domain.
According to the radiosensitivity parameters found in the
literature [41-43], only a fraction of mitotic cells are
assumed to be sensitive to the standard 2 Gy dose.
Model parameters
Cell cycle kinetic parameters were retrieved from flow
cytometric analysis of human colon cancer cells [35,44].
Table 3 summaries the quantitative parameters used in
our model.
Computational domain and initial conditions
In our two-dimensional model we study an 8 cm square
tissue. We assume that the domain comprises five small
circular tumor masses, the first located at the center of the
computational domain and the other four towards the
corners. Moreover, the domain has two sources of oxygen,
to the right and left sides of the central cell cluster (see Fig-
ure 4).
The number of cells in each tumor is the same, and they
are uniformly distributed. The number of cells in each
phase of the cell cycle is proportional to the duration of
the phase. For instance, the G1 phase contains twice as
many cells as the S phase because the G1 phase is twice as
long as the S phase. It is important to emphasize that the
cell cycle phases are discrete (see Section 2.7).
Table 3: Table of parameters Table of numerical parameters used for simulations.
Model parameters
Parameter Description Unit Value Reference
Duration of G1 phase h 20 [35,44]
TS Duration of S phase h 10 [35,44]
Duration of G2M phase h 3[ 3 5 , 4 4 ]
Duration of G0 phase h 5E s t i m a t e d
TApoptosis Duration of the apoptotic phase h 5E s t i m a t e d
Cmax Oxygen in blood mlO2 10-2 Estimated
αφ Oxygen consumption in phase φ mlO2s-1 5 – 10 × 10-15 Estimated
Tho Hypoxia threshold cell-1 5 × 10-15 Estimated
Tht Overpopulation threshold cell 2000 Estimated
Rφ Cell Radio-sensitivity in phase φ Gy-1 0.2 – 2 [41-43]
k Media permeability m2 0.2 Estimated
TG1
TGM 2
TG0Theoretical Biology and Medical Modelling 2006, 3:7 http://www.tbiomed.com/content/3/1/7
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Simulation technique
The model is fully deterministic. Cell cycle phases dura-
tions τφ have been discretized in several elementary age
intervals a ∈ {1, ..., Nφ} where Nφ is an integer such as τφ
= dt × Nφ. Here dt is the time step of the cell cycle model.
The cell density na, φ at age a in phase φ is governed by:
In this equation, φ ∈ {G1, S, G2M, G0, Apoptosis} and a ∈
{1, ..., Nφ}. Pa,φ is the cell density proliferation term in
phase φ at age a retrieved from the cell cycle model. In the
simulations, the intracellular and extracellular conditions
were identified for cells at the end of G1 phase. These were
used as initial conditions for the gene level model. The
genetic model was computed until it reached steady state
(this is of the order of 10 iterations).
Noting that   is constant, we can sum Eqs. (8) to
obtain an expression for the pressure field of the form:
The computer program starts from an initial distribution
of cells in each state {a, φ}. The computations are per-
formed using a splitting technique. First we run the cell
cycle model for one time-step dt, then retrieve new values
for na,φ and compute Pa, φ. Pressure is retrieved by solving
Eq. (9) and velocity is computed using Darcy's law (see
Eq. (1)). Since the contribution of the source term has
been taken into account by the cell cycle model at the first
stage of the splitting technique, Eqs. (8) are solved contin-
uously and without second members:
which can also be written [using (9)]:
This equation is then solved using a splitting technique.
The advection parts of Eq. (11) are solved by sub-cycling
finite different scheme computations, with time-step dtadv
being smaller than dt (for stability reasons). We set na,φ =
0 on the part of the boundary where v·υ < 0, υ denoting
the outgoing normal to the boundary. For the pressure p,
we set p = 0 on the boundary.
All simulations (except the ones shown in Figure 7) were
run for 320 h with time step dt = 1 h in a discrete compu-
tational domain composed by 100 × 100 elementary spa-
tial units.
Results and discussion
We divide our results and discussion into three parts. The
first section concerns simulations of the model without
therapeutic interactions (Sections 3.1–3.2). The second
part deals with the interactions between tumor growth
and the effect of therapeutic protocols (Section 3.3).
Finally, we investigate the sensitivity of the results to
model parameters and initial conditions (Section 3.4).
Genetic mutations are simulated by running the model,
having set the Boolean values of particular genes constant
(see Table 2). Since the genetic model is run until steady
state is reached, simulation of mutated cell growth is
equivalent to simulation of cells that are not sensitive to
particular anti-growth signals. In the following, we will
refer to cells with at least one mutation as 'cancer cells'.
Cells with no mutations are called 'normal cells'.
Gene-dependent tumor growth regulation
Figure 5 shows the simulated growth of cell colonies.
According to the model settings, the colony of normal
cells grows up to 106 cells and is then regulated through
activation of gene APC  owing to overpopulation. APC
mutated tumor cells are not sensitive to overpopulation
and reproduce exponentially until late regulation because
of hypoxia, through SMAD  gene activation. Finally,
according to the model parameters, APC and SMAD/RAS
∂
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Initial conditions Figure 4
Initial conditions. Schematic representation of the two-
dimensional computation domain for model simulations, with 
the initial spatial configuration of the cells. The domain is 
composed of five cell clusters and two blood vessels.Theoretical Biology and Medical Modelling 2006, 3:7 http://www.tbiomed.com/content/3/1/7
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mutated tumor cells cannot be regulated at all and thus
induce an exponential growth profile.
The simulation results reproduce the evolution of colorec-
tal cancer [16,45]. Indeed, APC has been shown to pro-
mote shifts in pattern of the normal cell population in
early colorectal tumorigenesis, and SMAD/RAS mutations
promote evolution from early adenoma to adenocarci-
noma.
Features of anti-growth signals and effect on tumor growth
APC-dependent growth regulation
The top diagram of Figure 6 shows the evolution of the
total and quiescent cell numbers, when population
growth is regulated through activation of the APC gene
due to overpopulation. Figure 6 shows that the first 100
hours are characterized by oscillations in both popula-
tions, which slowly disappear and become linear growth.
Indeed, as the cell population begins to grow, it tends to
activate APC signaling owing to overpopulation in the
inner part of the tumor masses. This results in a rapid
increase in the number of quiescent cells, which in turn
slows cell proliferation. Cell advection leads to invasion
of new tissues, which promotes proliferation and in turn
slows the evolution of the quiescent cell population.
These oscillations in cell population are caused by a com-
bination of overpopulation signal propagation in the
inner parts of the cell clusters and the cells' ability to move
to colonize free space. Very soon, what was once free space
becomes overpopulated. This results in a constant propor-
Cell population growth Figure 5
Cell population growth. Cell population growth (log plot) over time according to three different genetic profiles: normal 
cells (black diamonds), APC mutated cells (dashed line), and APC + SMAD/RAS mutated cells.Theoretical Biology and Medical Modelling 2006, 3:7 http://www.tbiomed.com/content/3/1/7
Page 9 of 19
(page number not for citation purposes)
tion of new cells becoming quiescent (see the late phase
of the curves Figure 6). The two snapshots presented at the
bottom of Figure 6 show the spatial distribution of all
cells (left), and that of mitotic cells only (right). Mitotic
cells are situated on the outer region owing to overpopu-
lation in the central parts of the clusters.
APC-dependent growth regulation Figure 6
APC-dependent growth regulation. Top: Evolution of the number of quiescent cells and total number of cells over time 
(log plot). Cell population is regulated through APC activation owing to overpopulation. Total cell number (continuous line) and 
number of quiescent cells (dotted line). Bottom: Snapshots of cells within the computational domain during simulation (t = 100 
h). Left: Total cell number. Right: Mitotic cells are only in the outer region of the tumor masses. Cells at the core are quiescent 
through APC activation due to overpopulation.Theoretical Biology and Medical Modelling 2006, 3:7 http://www.tbiomed.com/content/3/1/7
Page 10 of 19
(page number not for citation purposes)
SMAD/RAS-dependent growth regulation
Figure 7 shows the time courses of total cell number and
quiescent cell number. In this figure, cells are APC
mutated and the growth regulation is controlled by
SMAD/RAS  signaling, which has been activated by
hypoxia. Before hypoxia, cell population growth is expo-
nential and becomes more linear as the anti-growth sig-
nals start.
Figure 8 shows the evolution of the number of spatial
units in the computational domain co-opted by the two
regulation signals. The overpopulation and hypoxia signal
curves can be related to the evolution of the quiescent
cells from Figure 6 and Figure 7 respectively. Figure 8
reveals the difference in evolution between the hypoxia
and overpopulation signaling within the computational
domain. The first oscillating growth phase depicted in Fig-
ure 6 is caused by the step-by-step evolution of the over-
population signal activation. Hypoxia activation depicted
in Figure 8 appears later and displays a sharp increase.
While the overpopulation signal is local – it depends only
on the local conditions – activation of the hypoxia signal
is due to non-local effects. Oxygen absorbed by the cells at
a particular position is not available for neighboring cells.
SMAD/RAS-dependent growth regulation Figure 7
SMAD/RAS-dependent growth regulation. Evolution of the number of quiescent cells and total number of cells over time 
(log plot). An APC mutated cell population is regulated through SMAD/RAS activation due to hypoxia. Total number of cells 
(continuous line) and number of quiescent cells (dotted line).Theoretical Biology and Medical Modelling 2006, 3:7 http://www.tbiomed.com/content/3/1/7
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This results in regular signal propagation within the inner
parts of the cell clusters as shown in the snapshots of Fig-
ure 9. Hypoxia starts from an outer area of the computa-
tional domain, i.e. areas more distant from the oxygen
sources, and later occurs in the central cell cluster, where
oxygen concentration is highest.
Influence of gene-dependent growth regulation on the 
response to irradiation protocols
Simulated irradiation protocols on APC and SMAD/RAS mutated 
tumor cells
Figure 10 shows the evolution of the number of mutated
cells going through apoptosis due to the standard irradia-
tion protocol. In our model the treatment damages a con-
stant fraction of mitotic cells. APC  and  SMAD/RAS
mutated cells are not sensitive to anti-growth signals; they
are in hypoxic and overpopulation conditions that lead
mitotic cells to grow without regulation. Therefore the
number of apoptotic cells is increased by the irradiation
treatment. However, the number of apoptotic cells result-
ing from one treatment cycle is strictly equivalent to that
induced by the previous therapeutic cycle. This is due to
the difference between cell cycle duration (33 hours) and
application of the treatment (24 hours).
Simulated irradiation protocols and APC-dependent tumor growth
When cells are sensitive to overpopulation (see growth
curves Figure 6), population growth becomes linear after
a first oscillating stage. Figure 11 shows the difference in
efficacy between two irradiation protocols that are strictly
equivalent in terms of the total dose delivered. The first is
the standard protocol (dashed line), where the two doses
Anti-growth signals Figure 8
Anti-growth signals. Number of spatial units of the computation domain co-opted by the two regulation signals. The two 
curves show the activation of the hypoxia signal (continuous line) and the overpopulation signal (dashed line) over time. The 
vertical axis represents the number of elementary spatial units of the computational domain.Theoretical Biology and Medical Modelling 2006, 3:7 http://www.tbiomed.com/content/3/1/7
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are delivered with a 24 h interval. The second is a heuristic
approach, in which we optimized delivery of the second
dose by taking account of cell cycle regulation; the second
treatment is given when the number of the mitotic cells
reaches a maximum. The first treatment application
decreases the number of tumor cells. (Note that the dotted
line in Figure 11 is hidden by the continuous line.) This
also occurs in the second treatment of the heuristic proto-
Evolution of the spatial distribution of mitotic cells Figure 9
Evolution of the spatial distribution of mitotic cells. Temporal propagation of hypoxia signal within the tumor masses. 
Inner black areas are cells in quiescence due to SMAD/RAS activation through hypoxia. The spatial distribution of mitotic cells 
at: top-left 48 h, top-right 112 h, middle-left 168 h, middle-right 224 h, bottom-left 290 h, bottom-right 336 h.Theoretical Biology and Medical Modelling 2006, 3:7 http://www.tbiomed.com/content/3/1/7
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col. However, when the second treatment is delivered
without taking growth regulation into account, i.e. stand-
ard scheduling, the efficacy is very poor (see Figure 11).
Simulated irradiation protocols on APC-mutated (SMAD/RAS-
dependent) tumor growth regulation profiles
Figure 12 shows the evolution of the irradiated target cell
population fraction, by which we mean the time course of
the mitotic fraction without irradiation, before and after
activation of the hypoxia signal. As soon as the hypoxia
appears, the mitotic fraction collapses. Table 1 shows the
difference in simulated efficacy between two equivalent
protocols in terms of total dose. The first is the standard
protocol, where the 2Gy treatments are given daily, 5 days
a week for 2 weeks, with a total dose of 20Gy. The second
is the heuristic treatment, in which all 10 doses of 2Gy are
given before the hypoxia signals appear. Part of the stand-
ard treatment is delivered while the tumors are becoming
hypoxic (mitotic fraction falls), and this results in a
decrease in efficacy. In contrast, all 10 doses in the heuris-
tic treatment are delivered before hypoxia, which gives
improved efficacy.
Sensitivity to model parameters and initial conditions
We study the potential influence of the choice of parame-
ters values on the model's results. The most critical param-
eters to account for include:
• cell-specific radiosensitivity parameters (αφ);
Apoptotic activity Figure 10
Apoptotic activity. Number of cells in the apoptotic phase over time when applying the standard radiotherapeutic protocol: 
2 Gy daily. Vertical black arrows indicate treatment delivery times. Note that apoptotic activity appears at a fixed time after 
treatment delivery. This is the time needed for the G2M DNA-injured cells to reach the restriction point of the cell cycle (21 
hours according to the model parameters).Theoretical Biology and Medical Modelling 2006, 3:7 http://www.tbiomed.com/content/3/1/7
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Comparison of two radiotherapeutic protocols Figure 11
Comparison of two radiotherapeutic protocols. Top: Total cell number in response to standard therapeutic scheduling, 
i.e. 2 Gy applied twice within a 24 hour interval, and in response to a heuristic scheduling. Note that for the first 40 hours, the 
dotted line is superimposed on the continuous line since until the treatments diverge the populations are the same. Bottom: 
Evolution of the number of apoptotic cells due to irradiation protocols. The first treatment induces the same number of apop-
totic cells. The effect of the second treatment in the standard protocol is negligible (black diamonds around time 50 h) in con-
trast to the heuristic approach (white diamonds pick at 40 h). Treatment delivery times are symbolized by vertical arrows: 
unfilled diamonds for the standard scheduling and solid diamonds for the heuristic approach.Theoretical Biology and Medical Modelling 2006, 3:7 http://www.tbiomed.com/content/3/1/7
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• anti-growth signals, i.e. hypoxia and overpopulation,
activation thresholds above which cells go into quiescence
(Tho and Tht);
• initial conditions, i.e. initial number of cells and spatial
configurations of oxygen sources.
Treatment protocol efficacy depends directly on cell-spe-
cific radiosensitivity parameters. Figure 13 compares the
evolution of total cell number over time when the stand-
ard treatment protocol is applied. Model simulations
show that the standard treatment is efficient when the
parameters make cells in G1 phase become radiosensitive.
APC  and  SMAD/RAS  activation, which leads cells to
become quiescent, is controlled by the two threshold
parameters Tht and Tho. Increasing Tht results in delay of
the overpopulation signal, while increasing Tho speeds
hypoxia activation.
Decreasing the initial number of cells has the same effect
as increasing Tht, while decreasing the number or the ini-
tial strength of the oxygen sources has the same effect as
increasing Tho. The initial configuration of tumor cells and
oxygen sources is important for spatial propagation of the
hypoxia signal. Indeed, Figure 9 shows a particular
hypoxia propagation in the tumor cell masses that is cor-
related with the locations of the oxygen sources. Since Tht
and Tho are merely constants, it seems that we may change
Evolution of simulated mitotic fraction of APC-mutated cells over time without irradiation Figure 12
Evolution of simulated mitotic fraction of APC-mutated cells over time without irradiation. The vertical dashed 
line indicates the time when the hypoxia signal is activated.Theoretical Biology and Medical Modelling 2006, 3:7 http://www.tbiomed.com/content/3/1/7
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the spatial configuration and size of the initial cell popu-
lation and vary the oxygen sources and yet produce the
same qualitative results.
Finally, Figure 14 shows the difference in evolution of the
overpopulation signal over time if the initial distribution
of cells in the clusters is uniform or random. The step by
step evolution of overpopulation activation is softened
but still exists when the cells are randomly distributed
within the initial tumor masses.
Conclusion
We have presented a multiscale model of cancer growth
and examined the qualitative response to radiotherapy.
The mathematical framework includes a Boolean descrip-
tion of a genetic network relevant to colorectal oncogene-
sis, a discrete model of the cell cycle and a continuous
macroscopic model of tumor growth and invasion. The
basis of the model is that the sensitivity to irradiation
depends on cell cycle phase and that DNA damage is pro-
portional to the radiation dose. Anti-growth regulation
signals such as hypoxia and overpopulation activate the
SMAD/RAS and APC genes, respectively, and inhibit pro-
liferation through cell cycle regulation.
Simulation results show the different features of the anti-
growth signal activation and propagation within the
tumor (see Figure 8). The overpopulation signal mediated
by the APC gene initially induces oscillatory growth owing
to a combination of proliferating and quiescent cells (see
Effect of radiosensitivity parameters on treatment efficacy Figure 13
Effect of radiosensitivity parameters on treatment efficacy. Evolution of total cell number over time with the standard 
radiosensitivity parameters (continuous line), and with the suggested parameters. This shows that, with the new treatment, 
cells in G1 phase are sensitive to the 2 Gy treatment dose.Theoretical Biology and Medical Modelling 2006, 3:7 http://www.tbiomed.com/content/3/1/7
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Figure 6). Because of its non-local effect, the hypoxia sig-
nal mediated by genes SMAD/RAS appears later but devel-
ops quickly within the tumor masses, and leads the
mitotic fraction to collapse (see Figures 11 and 14). These
features make the evolution of the number of quiescent
cells and thus the efficacy of irradiation protocols depend
on the type of anti-growth signals to which the tumors are
exposed. Figure 11 and Table 1 show that efficacy could be
improved, without increasing radiation doses, by plan-
ning schedules that take account of the features of tumor
growth through cell cycle regulation.
The proposed framework emphasizes the significant role
of gene-dependent cell-cycle regulation in the response of
tumors to radiotherapy. Clinical studies have recognized
p53 status as a major predictive factor for the response of
rectal cancer to irradiation. Nevertheless, some results
encourage investigation of other different factors [46]. In
particular, it has been suggested that macroscopic factors
such as hypoxia and tumor volumes are important [47].
The present modeling framework integrates these factors
through cell cycle regulation and allows consideration of
other factors at the genetic, cellular or tissue level.
Some modeling assumptions must be discussed. We
chose a continuous approach that provides cell density
rather than actual cell number. This assumes that the
region of interest is large since we have restricted our anal-
ysis to late-stage tumor development. We have not consid-
ered cell shape, which has been shown to be important for
the correct description of growth control processes [48].
Individual-based models of cell movement, e.g. the Potts
Effect of cell distribution within the initial cell clusters on overpopulation Figure 14
Effect of cell distribution within the initial cell clusters on overpopulation. The vertical axis is the number of elemen-
tary spatial units of the computational domain. Here we show the difference between evolution of the overpopulation signal 
over time when cells in the clusters are initially distributed uniformly or randomly. The evolution of overpopulation activation 
is softened but still exists when cells are randomly distributed within the initial tumor masses.Theoretical Biology and Medical Modelling 2006, 3:7 http://www.tbiomed.com/content/3/1/7
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model [49,50] and the Langevin model [51], would
improve our approach. We reduced the system to two
dimensions. A three-dimensional tumor model could
reveal new factors in the dynamics.
The aim of this study is to understand the qualitative effect
of therapeutic protocols on colorectal cancer. Our analysis
raises some interesting points about the influence of anti-
growth regulation signals and genetic pathways on the
efficacy of the standard protocol. Efforts have been made
to improve the LQ model by taking into account multiple
factors such as tumor volume and repopulation between
treatment cycles [52]. However, we have produced a mul-
tiscale model that is more realistic and demonstrated its
use in comparing efficacy of treatment protocols.
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